pyrazole has been researched along with Hepatocellular Carcinoma in 6 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Dömötör, O | 1 |
Kiss, MA | 1 |
Gál, GT | 1 |
May, NV | 1 |
Spengler, G | 1 |
Nové, M | 1 |
Gašparović, AČ | 1 |
Frank, É | 1 |
Enyedy, ÉA | 1 |
Elshaier, YAMM | 1 |
Shaaban, MA | 1 |
Abd El Hamid, MK | 1 |
Abdelrahman, MH | 1 |
Abou-Salim, MA | 1 |
Elgazwi, SM | 1 |
Halaweish, F | 1 |
Harras, MF | 1 |
Sabour, R | 1 |
Hawash, MM | 1 |
Kahraman, DC | 1 |
Eren, F | 1 |
Cetin Atalay, R | 1 |
Baytas, SN | 1 |
Nieto, N | 1 |
Marí, M | 1 |
Cederbaum, AI | 2 |
Wu, D | 1 |
6 other studies available for pyrazole and Hepatocellular Carcinoma
Article | Year |
---|---|
Solution equilibrium, structural and cytotoxicity studies on Ru(η
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Proliferation; C | 2020 |
Design and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Drug Design; Hep G | 2017 |
Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; CDC2 Protein Kinase; Cell Cy | 2018 |
Synthesis and biological evaluation of novel pyrazolic chalcone derivatives as novel hepatocellular carcinoma therapeutics.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Cycle Prot | 2017 |
Cytochrome P450 2E1 responsiveness in the promoter of glutamate-cysteine ligase catalytic subunit.
Topics: 5' Flanking Region; Allyl Compounds; Animals; Antioxidants; Arachidonic Acid; Carcinoma, Hepatocellu | 2003 |
Sodium salicylate increases CYP2E1 levels and enhances arachidonic acid toxicity in HepG2 cells and cultured rat hepatocytes.
Topics: Allyl Compounds; Animals; Antioxidants; Apoptosis; Arachidonic Acid; Carcinoma, Hepatocellular; Cell | 2001 |